Multiple Sclerosis
Apixaban, aspirin comparable for patients with cancer history, cryptogenic stroke
Apixaban and aspirin offered similar protection against major ischemic and hemorrhagic events among people with cancer history and cryptogenic stroke.
FDA clears clinical trial on novel MS cell therapy platform
The FDA has cleared an investigational new drug application for a phase 1 clinical trial evaluating a universal, allogenic cell therapy platform intended to treat progressive MS.
‘Quite striking’: Donor socioeconomic status may affect stem cell transplant outcomes
The socioeconomic status of cell donors may affect outcomes of people with blood cancer who undergo hematopoietic stem cell transplantation, according to retrospective study results.
Cardiovascular, thromboembolic events more closely tied to kidney vs. glomerular disease
Incident cardiovascular and thromboembolic events may be more closely linked to the severity of kidney disease than with glomerular disease subtype, according to results of a prospective study.
‘Even one meal change’ to vegetarian, vegan can reduce serum ammonia in cirrhosis
Substitution of just one meat-based meal with a vegetarian or vegan alternative reduced serum ammonia levels for up to 3 hours and improved metabolites in patients with cirrhosis who follow a Western meat-based diet, researchers reported.